| pubmed-article:2642458 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2642458 | lifeskim:mentions | umls-concept:C0149615 | lld:lifeskim |
| pubmed-article:2642458 | lifeskim:mentions | umls-concept:C0011304 | lld:lifeskim |
| pubmed-article:2642458 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:2642458 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:2642458 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2642458 | pubmed:dateCreated | 1989-2-6 | lld:pubmed |
| pubmed-article:2642458 | pubmed:abstractText | Neurological complications associated with cyclosporin administration are well documented. However their histopathological basis are ill-understood. We describe below a case of demyelination following cyclosporin administration to a patient following allogeneic bone marrow transplantation. | lld:pubmed |
| pubmed-article:2642458 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2642458 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642458 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2642458 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2642458 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2642458 | pubmed:issn | 0278-0232 | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:LandE JEJ | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:ChangJJ | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:ScarffeJ HJH | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:JinTT | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:MorgensternG... | lld:pubmed |
| pubmed-article:2642458 | pubmed:author | pubmed-author:McWilliamLL | lld:pubmed |
| pubmed-article:2642458 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2642458 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:2642458 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2642458 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2642458 | pubmed:pagination | 49-52 | lld:pubmed |
| pubmed-article:2642458 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:meshHeading | pubmed-meshheading:2642458-... | lld:pubmed |
| pubmed-article:2642458 | pubmed:articleTitle | Cyclosporin associated demyelination following allogeneic bone marrow transplantation. | lld:pubmed |
| pubmed-article:2642458 | pubmed:affiliation | CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, U.K. | lld:pubmed |
| pubmed-article:2642458 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2642458 | pubmed:publicationType | Case Reports | lld:pubmed |
